Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Kempharm Inc

(NASDAQ: KMPH)
Add to Portfolio
-0.01 (-1.14%)
as of Sep 16, 2019

Last 0.87
Change -0.01 (-1.14%)
Open 0.89
Prev. Close 0.88
Today's Range
0.86
0.90
52wk Range
0.71
5.43
Volume 136,051
Avg Volume 349,828
Sector All Sectors By Industry

Perfomance Comparison

Name Today 3-Month 1-Year
KMPH -1.14% -45.63% -83.11%
DJIA -0.52% +0.57% +3.53%
S&P 500 -0.31% +0.25% +3.20%

Key Statistics

Annual EPS -1.93
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 26,490
Weighted Alpha -74.07
Standard Deviation -0.15
Profit Margin N/A
Beta 1.47

Growth Rates

YTD -51.12%
1-Year -82.91%
3-Year -80.04%

Opinion

Sell Hold Buy

Recent Headlines

KemPharm to Present at the 21st Annual Global

GlobeNewswire via COMTEX - Thu Sep 05, 07:30AM EDT
KemPharm, Inc. (Nasdaq:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced that its president and chief executive officer, Travis C. Mickle, Ph.D., will prese(full story)
KMPH: 0.87 (-0.01)

KemPharm Announces Entry into Definitive Collaboration

GlobeNewswire via COMTEX - Wed Sep 04, 08:01AM EDT
Up to a Total of $493 Million in Upfront, Sales and Development Milestone Payments, as well as Royalties on Net Sales(full story)
KMPH: 0.87 (-0.01), PTCI: 0.5500 (+0.1500)

KemPharm Reports Second Quarter 2019 Results

GlobeNewswire via COMTEX - Tue Aug 13, 05:00PM EDT
KemPharm, Inc. (Nasdaq: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, today reported its corporate and financial results for the quarter ended June 30, 2019.(full story)
KMPH: 0.87 (-0.01)

KemPharm to Present at Upcoming Investor Conferences

GlobeNewswire via COMTEX - Tue Mar 05, 07:29AM EST
KemPharm, Inc. (Nasdaq:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced that management will present at several investor conferences during March 2019.(full story)
KMPH: 0.87 (-0.01)

KemPharm to Report Fourth Quarter and Year End 2018

GlobeNewswire via COMTEX - Thu Feb 21, 04:15PM EST
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Thursday, February 28, 2019, 4:30 p.m. ET(full story)
KMPH: 0.87 (-0.01)